IL6 and Nasal polyposis: More specifically, peptide therapy reduced the levels of the pro-inflammatory cytokine IL-6, overexpression of which has been associated with development of nasal polyps in chronic rhinosinusitis (Min and Lee, 2000), without reducing the chemokine KC, which is important for neutrophil recruitment to the site of infection (Min and Lee, 2000).